Although in many cancers sFRP1 is inactivated due to epigenetic modification [27–28], but it is also known to be over-expressed in gastric cancer and renal cell carcinoma [29–30] where it is associated with tumor aggressiveness, metastasis, and decreased overall survival. This evidence concerns the gene SFRP1 and neoplasm.